Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 15.2T | 14.3T | 14.2T | 13.4T |
Cost of revenue | 5.0T | 4.6T | 4.6T | 4.8T |
Gross profit | 10.2T | 9.7T | 9.7T | 8.6T |
Operating expense | ||||
Research & development | 2.9T | 2.6T | 2.1T | 2.1T |
Selling general and admin | 1.0T | 1.0T | 905.3B | 963.5B |
Other operating expenses | — | — | — | — |
Operating income | 5.8T | 5.6T | 6.1T | 4.7T |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 769.9B | 733.6B | 832.8B | 873.9B |
Other income expense | 17.2B | -58.2B | -65.8B | -693.6B |
Pretax income | 5.0T | 4.9T | 5.2T | 3.6T |
Tax provision | 1.1T | 114.5B | -12.4B | -421.7B |
Net income | 3.9T | 4.7T | 5.2T | 4.1T |
Basic EPS | 0.9 | 1.1 | 1.2 | 0.9 |
Diluted EPS | 0.9 | 1.0 | 1.1 | 0.9 |
Basic average shares | 4.5T | 4.5T | 4.5T | 4.5T |
Diluted average shares | 4.6T | 4.6T | 4.6T | 4.6T |
EBITDA | 8.1T | 7.7T | 8.3T | 7.3T |
Net income from continuing op. | 3.9T | 4.7T | 5.2T | 4.1T |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |